CD274 and neoplasm: Furthermore, while T cell receptor-engineered T (TCR-T) cell therapy has shown promising results in treating solid tumors 29, few studies have systemically investigated how tumor PD-L1 can affect the functionality of tumor antigen-specific TCR-T cells.